The DOI matches its Crossref record; 215 of the 215 references it cites were found in a registry or an index.
Spinal Muscular Atrophy
Open accessAbstract
Incidence The incidence of SMA is 1:11,000 live births [1]. Prevalence The prevalence of the carrier state is approximately 1 in 54 [1]. Severity The clinical severity of SMA correlates inversely with SMN2 gene copy number and varies from an extreme weakness and paraplegia of infancy to a mild proximal weakness of adulthood. Natural History The natural history of SMA is complex and variable. For this reason, clinical subgroups have been defined based upon best motor function attainment during development. Type 1 SMA infants never sit independently. Type 2 SMA children sit at some point during their childhood, but never walk independently. And Type 3 SMA children and adults are able to walk independently at some point in their childhood.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–215 of 215
Antisense oligonucleotides and spinal muscular atrophy: skipping along: Figure 1.Preprint
Burghes, A. H. M., & McGovern, V. L. (2010) · Genes & Development · doi:10.1101/gad.1961710 · Cited by 41
Cobb, M. S., Rose, F. F., Rindt, H., Glascock, J., Shababi, M., Bolding, M., Osman, E. Y., Yen, P., Garcia, M. L., Martin, B. R., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt037 · Cited by 41
Epidemiological data on Werdnig-Hoffmann disease in Germany (West-Th�ringen)
Thieme, A., Mitulla, B., Schulze, F., & Spiegier, A. J. (1993) · Human Genetics · doi:10.1007/bf00218278 · Cited by 40
Carrier testing for spinal muscular atrophy
Gitlin, J. M., Fischbeck, K. H., Crawford, T. O., Cwik, V. A., Fleischman, A. R., Gonye, K., Heine, D., Hobby, K., Kaufmann, P., Keiles, S. B., et al. (2010) · Genetics in Medicine · doi:10.1097/gim.0b013e3181ef6079 · Cited by 34
Prevalence of type I spinal muscular atrophy in North Dakota
Burd, L., Short, S. K., Martsolf, J. T., & Nelson, R. A. (1991) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320410216 · Cited by 33
Jong, Y., Chang, J., Lin, S., Yang, T.-Y., Wang, J., Chang, C., Lee, C., Li, H., Hsieh-Li, H.-M., & Tsai, C. (2000) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00325-1 · Cited by 32
Boitano, L. J. (2009) · PEDIATRICS · doi:10.1542/peds.2008-2952f · Cited by 32
Public attitudes regarding a pilot study of newborn screening for spinal muscular atrophy
Rothwell, E., Anderson, R. A., Swoboda, K. J., Stark, L. A., & Botkin, J. R. (2013) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.35756 · Cited by 31
RNA processing defects associated with diseases of the motor neuron
Kolb, S. J., Sutton, S., & Schoenberg, D. R. (2009) · Muscle & Nerve · doi:10.1002/mus.21428 · Cited by 31
Self-citationLúðvígsson, P., Ólafsson, E., & Hauser, W. A. (1999) · Neuroepidemiology · doi:10.1159/000026221 · Cited by 29
Solving the puzzle of spinal muscular atrophy: What are the missing pieces?
Tiziano, F. D., Melki, J., & Simard, L. R. (2013) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36251 · Cited by 26
Sense in Antisense Therapy for Spinal Muscular Atrophy
MacKenzie, A. (2012) · New England Journal of Medicine · doi:10.1056/nejmcibr1114629 · Cited by 18
A Negatively-Acting Bifunctional RNA Increases Survival Motor Neuron in vitro and in vivo
Dickson, A., Osman, E. Y., & Lorson, C. L. (2008) · Human Gene Therapy · doi:10.1089/hgt.2008.067 · Cited by 18
Markström, A., Cohen, G., & Katz‐Salamon, M. (2010) · Sleep Medicine · doi:10.1016/j.sleep.2009.08.014 · Cited by 14
Naryshkin, N. A., Narasimhan, J., Dakka, A., Gabbeta, V., Haley, M. M., Jung, S. P., Crona, J. H., Vazirani, P., Furia, B., Qi, H., et al. (2012) · Neuromuscular Disorders · doi:10.1016/j.nmd.2012.06.153 · Cited by 6
Cited by
Splice-switching antisense oligonucleotides as therapeutic drugs
Havens, M. A., & Hastings, M. L. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw533 · Cited by 538
Antisense technology: A review
Crooke, S. T., Liang, X.-H., Baker, B. F., & Crooke, R. M. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100416 · Cited by 326
A Decade of FDA-Approved Drugs (2010–2019): Trends and Future Directions
Brown, D. G., & Wobst, H. J. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01516 · Cited by 320
Chand, D., Mohr, F., McMillan, H., Tukov, F. F., Montgomery, K., Kleyn, A., Sun, R., Tauscher-Wisniewski, S., Kaufmann, P., & Kullak-Ublick, G. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2020.11.001 · Cited by 306
DNA copy number variation: Main characteristics, evolutionary significance, and pathological aspects
Pös, O., Radvanszky, J., Buglyó, G., Pös, Z., Rusnakova, D., Nagy, B., & Szemes, T. (2021) · Biomedical Journal · doi:10.1016/j.bj.2021.02.003 · Cited by 276
Metadata
- Authors
- Kolb, S. J., & Kissel, J. T.
- Venue
- Neurologic Clinics
- Publisher
- Elsevier BV
- Published
- 2015-11
- Volume
- 33
- Issue
- 4
- Pages
- 831-846
- ISSN
- 0733-8619 (ISSN-L)
- OpenAlex
- W1871235281
- Cited by
- 603
- References
- 215
- FWCI
- 9.13
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.